Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Cerilliant
Federal Trade Commission
Fish and Richardson
Merck
Medtronic
US Army
Farmers Insurance
McKesson
UBS

Generated: August 16, 2017

DrugPatentWatch Database Preview

Rifabutin - Generic Drug Details

« Back to Dashboard

What are the generic sources for rifabutin and what is the scope of rifabutin patent protection?

Rifabutin
is the generic ingredient in two branded drugs marketed by Lupin Ltd and Pharmacia And Upjohn, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for rifabutin. Seven suppliers are listed for this compound.

Summary for Generic Name: rifabutin

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list3
Suppliers / Packagers: see list7
Bulk Api Vendors: see list29
Clinical Trials: see list64
Patent Applications: see list7,575
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:rifabutin at DailyMed

Pharmacology for Ingredient: rifabutin

Ingredient-typeRifamycins
Drug ClassRifamycin Antimycobacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
MYCOBUTIN
rifabutin
CAPSULE;ORAL050689-001Dec 23, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Lupin Ltd
RIFABUTIN
rifabutin
CAPSULE;ORAL090033-001Feb 24, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
AstraZeneca
Express Scripts
US Department of Justice
McKinsey
UBS
Moodys
Baxter
Fuji
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot